Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yvonne Grübler
Observed names:
Y Gruebler,
Y Grübler,
Y. Grübler,
Yvonne Gruebler,
Yvonne Grübler
Institution:
Molecular Partners (Switzerland)
Observed institutions:
Max Planck Society,
Universidad de Buenos Aires,
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Molecular Partners (Switzerland),
Institute for Medical Research,
Max Planck Institute of Psychiatry
show all 6
ORCID:
0009-0004-4046-2995
Observed ORCID:
0009-0004-4046-2995
OpenAlex ID:
A5032190225
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
2003
·
Daniela Cota
, Giovanni Marsicano
, et al.
·
Journal of Clinical Investigation
·
1,205
PDF
Requirement of Cannabinoid Receptor Type 1 for the Basal Modulation of Hypothalamic-Pituitary-Adrenal Axis Function
2006
·
Daniela Cota
, Michel-Alexander Steiner
, et al.
·
Endocrinology
·
219
Retinoic acid prevents experimental Cushing syndrome
2001
·
Marcelo Páez-Pereda
, Damian Kovalovsky
, et al.
·
Journal of Clinical Investigation
·
194
PDF
Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk
2003
·
Marcelo Páez-Pereda
, Damiana Giacomini
, et al.
·
Proceedings of the National Academy of Sciences
·
179
PDF
Normal Human Pituitary Gland and Pituitary Adenomas Express Cannabinoid Receptor Type 1 and Synthesize Endogenous Cannabinoids: First Evidence for a Direct Role of Cannabinoids on Hormone Modulation at the Human Pituitary Level
2001
·
U. Pagotto
, G. Marsicano
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
133
The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas.
2000
·
U Pagotto
, T Arzberger
, et al.
·
PubMed
·
123
Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells
2004
·
M Theodoropoulou
, T Arzberger
, et al.
·
Journal of Endocrinology
·
107
PDF
Hypothalamus–pituitary–adrenal axis during Trypanosoma cruzi acute infection in mice
2006
·
Eliane Corrêa-de-Santana
, Marcelo Paez-Pereda
, et al.
·
Journal of Neuroimmunology
·
84
Thyrotrophin receptor protein expression in normal and adenomatous human pituitary
2000
·
M Theodoropoulou
, T Arzberger
, et al.
·
Journal of Endocrinology
·
36
PDF
Nerve growth factor and retinoic acid inhibit proliferation and invasion in thyroid tumor cells
2000
·
M. Páez Pereda
, C. Missale
, et al.
·
Molecular and Cellular Endocrinology
·
30
The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
·
Cancer Immunology Research
·
17
PDF
MP0533: A Multispecific Darpin CD3 Engager Targeting CD33, CD123, and CD70 for the Treatment of AML and MDS Designed to Selectively Target Leukemic Stem Cells
2022
·
Matteo Bianchi
, Christian Reichen
, et al.
·
Blood
·
5
Abstract 1890: A solution to T-cell engager toxicity: An anti-CD3 Prodrug DARPin (CD3-PDD) shows no toxicity, but potent anti-tumor activity in a humanized mouse model
2021
·
Andreas Bosshart
, Julia Katharina Ahlskog
, et al.
·
Cancer Research
·
3
Abstract 525: Novel DARPin multi-specific T-cell engager with an improved therapeutic window to overcome dose limiting toxicities in AML therapies
2021
·
Nina Reschke
, Thamar Looser
, et al.
·
Cancer Research
·
3
842 Unlocking precision: a next-generation multi-specific CD3 Switch-DARPin with enhanced function to tackle the current limitations of T cell engagers in ovarian cancer
2024
·
Joanna Robinson
, Matteo Bianchi
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
Avidity-Engineered CD3 Engaging DARPin ® Targeting Three Tumor Associated Antigens Induce Strong and Specific T Cell Dependent Killing of AML Cells with Potential for Improved Safety
2021
·
Matteo Bianchi
, Nina Reschke
, et al.
·
Blood
·
1
Data from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S12 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
PDF
Supplementary Figure S1 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S16 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S2 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S15 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S3 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S5 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Supplementary Figure S13 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024
·
Matteo Bianchi
, Christian Reichen
, et al.
Show more works
View as search
Works count:
52
Citation count:
2,340
H-index:
11
I10-index:
11
Year
Topic
Type
